R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

How synthetic data is overcoming privacy challenges in healt...

The healthcare industry is saturated in data, but accessing the right data, at the right time, remains a persistent challenge.

R&D

Perspectives in viral clearance

Since the 1990s, viral clearance (VC) studies have been a critical safety step for biologic drugs.

R&D

Xenotransplantation at the brink of breakthrough: A new era ...

In a landmark procedure performed at Massachusetts General Hospital (MGH) on 25th January 2025, a 66-year-old man with end-stage renal disease (ESRD) received a genetically modif

R&D

Mind the gap: The need for gender-specific outcome measureme...

It is well documented that women face delayed diagnoses, mischaracterised symptoms, and experience more years of ill-health compared to men.

R&D

Can sound waves ease depression symptoms?

Depression affects more than 280 million people worldwide.

R&D

Why I'm focused on the trillion-dollar AMR crisis everyone's...

AMR demands sustained commitment beyond conventional market incentives.